top of page
We are pioneers in zinc research for brain injury and neurodegenerative disease.
History
-
The company established in 2020.03
-
lCurrent Investment: 1.5 M USD from Venture Capitals
-
Research : Acute Brain Injury, Neurodegenerative disease
-
Government Funded Research Projects
-
TIPS(Tech Incubator Program for Startup)
-
Multiple Sclerosis (Lead compound)
-
Grant 0.4M USD 2021.7~2023.6
-
-
KDDF(Korea Drug Development Fund)
-
Amyotrophic Lateral Sclerosis(Preclinical candidate)
-
Grant: 1M USD 2023.4~2025.3
-
-
-
Collaboration with Asan Medical Center, Hallym University, and Harvard Medical School
bottom of page